Infantile parkinsonism-dystonia: A dopamine "transportopathy"

Journal of Clinical Investigation

Volumn 119, Issue 6, 2009, Pages 1455-1458

  Blackstone, Craig ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE DISORDER; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; DYSTONIA; HUMAN; INFANCY; INFANT DISEASE; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; NOTE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPSE VESICLE;

ANIMALS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; INFANT; MUTATION; PARKINSONIAN DISORDERS;

EID: 67651007567     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39632     Document Type: Note

References (20)

1. Carlsson, A. 1987. Perspectives on the discovery of central monoaminergic neurotransmission. Annu. Rev. Neurosci. 10:19-40.
2. Carlsson, A. 2001. A paradigm shift in brain research. Science. 294:1021-1024.
3. Mehler-Wex, C., Riederer, P., and Gerlach, M. 2006. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox. Res. 10:167-179.
4. Yao, W.-D., Spealman, R.D., and Zhang, J. 2008. Dopaminergic signaling in dendritic spines. Biochem. Pharmacol. 75:2055-2069.
5. He, L., Vasiliou, K., and Nebert, D.W. 2009. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum. Genomics. 3:195-206.
6. Torres, G.E., and Amara, S.G. 2007. Glutamate and monoamine transporters: new visions of form and function. Curr. Opin. Neurobiol. 17:304-312.
7. --dependent neurotransmitter transporters. Nature. 437:215-223.
8. Krause, J. 2008. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev. Neurother. 8:611-625.
9. Gainetdinov, R.R. 2008. Dopamine transporter mutant mice in experimental neuropharmacology. Naunyn Schmiedebergs Arch. Pharmacol. 377:301-313.
10. Li, L.-B., et al. 2004. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279:21012-21020.
11. Miranda, M., Dionne, K.R., Sorkina, T., and Sorkin, A. 2007. Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell. 18:313-323.
12. Norregaard, L., Loland, C.J., and Gether, U. 2003. Evidence for distinct sodium-, dopamine-, and cocaine-dependent conformational changes in transmembrane segments 7 and 8 of the dopamine transporter. J. Biol. Chem. 278:30587-30596.
13. Mazei-Robison, M.S., et al. 2008. Anomalous dopamine release associated with a human dopamine transporter coding variant. J. Neurosci. 28:7040-7046.
14. Kurian, M.A., et al. 2009. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J. Clin. Invest. 119:1595-1603.
15. Zafeiriou, D.I., et al. 2009. Tyrosine hydroxylase deficiency with severe clinical course. Mol. Genet. Metab. 97:18-20.
16. Assmann, B.E., et al. 2004. Infantile parkinsonism-dystonia and elevated dopamine metabolites in CSF. Neurology. 62:1872-1874.
17. Lander, E.S., and Botstein, D. 1987. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science. 236:1567-1570.
18. Gibbs, J.R., and Singleton, A. 2006. Application of genome-wide single nucleotide polymorphism typing: simple association and beyond. PLoS Genet. 2:e150.
19. Nikolaus, S., et al. 2007. Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans. Rev. Neurosci. 18:439-472.
20. Nikolaus, S., et al. 2007. Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals. Rev. Neurosci. 18:473-504.